Compare BIO-TECHNE Corp (TECH) vs Union Pacific Corporation (UNP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Union Pacific Corporation — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Union Pacific Corporation trades at $279.21 (market cap $163.18B). The key difference: Union Pacific Corporation is far larger — about 14.4× BIO-TECHNE Corp's market cap, and Union Pacific Corporation pays the higher dividend (2.07%). Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Union Pacific Corporation for 105 Days on average.
| TECH | UNP | |
|---|---|---|
Market Cap | $11.37B | $163.18B |
Volume | 3,153,511 | 1,718,713 |
Sector | Health | Industrials |
52-Week High | $72.61 | $310.62 |
52-Week Low | $43.31 | $216.37 |
Typical Hold Time | 63 Days | 105 Days |
Enterprise Value | $11.40B | $192.24B |
Dividend Yield | 0.44% | 2.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Union Pacific (UNP) trades at $278.20, up 0.57% today, with a bearish technical signal despite strong earnings beats in Q1 and Q2 2026. The company maintains robust profitability with a net margin of 28.85% and ROE of 39.7%, supported by steady revenue growth and positive cash flow trends. Recent news highlights deployment of battery-electric locomotives and progress on the Norfolk Southern merger, though the stock faces near-term technical pressure.
The outlook remains positive with a consensus price target of $332.10, implying significant upside, but risks include merger uncertainty and fuel cost pressures. Strong institutional support and a 20-year dividend growth streak provide a solid foundation for long-term investors, though volatility may persist amid macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →
